Ratiometric Imaging Detection of Amyloid-β Fibrils by a Dual-Emissive Tris-Heteroleptic Ruthenium Complex
Two dual fluorescent/phosphorescent tris-heteroleptic mononuclear Ru(ΙΙ) complexes (<b>2</b> and <b>3</b>) were designed and applied in amyloid-β (Aβ) sensing. These complexes have a general formula of [Ru(phen)(dppz)(<b>L</b>)](PF<sub>6</sub>)<sub>2</sub>, where <b>L</b> is (2-pyrazinyl)(2-pyridyl)(methyl)amine (H-<b>L</b>) with different substituents (-OMe for <b>2</b>, -H for <b>3</b>), phen is 1,10-phenanthroline, and dppz is dipyridophenazine, respectively. Compared with the previously reported ratiometric probe <b>1</b> with a di(pyrid-2-yl)(methyl)amine ligand, complex <b>2</b> can be employed for not only ratiometric emissive detection of Aβ aggregation but also ratiometric imaging detection of Aβ fibrils. In ratiometric emissive detection, as the incubation time of the Aβ sample (Aβ<sub>40</sub> and Aβ<sub>42</sub>) was prolonged, a new phosphorescence emission band appeared with gradual enhancement of the emission intensity, while the fluorescence emission was basically unchanged, which could be treated as an intrinsic internal reference signal. In comparison, a larger ratiometric photoluminescence enhancement (<i>I</i><sub>640</sub>/<i>I</i><sub>440</sub>) was observed for Aβ<sub>40</sub> aggregation with respect to Aβ<sub>42</sub>. In ratiometric imaging detection, the imaging signals obtained from the phosphorescence emission are much brighter than the fluorescence emission in both Aβ<sub>40</sub> and Aβ<sub>42</sub> fibrils. As indicated by molecular docking results, stronger interactions were found between complex <b>2</b> with Aβ<sub>40</sub> fibrils, which included π/π, π/C-H, and π/H interactions between bidentate ligands dppz and phen with amino acid residues. Moreover, computational calculations were carried out to assist the interpretation of these experimental findings.
Authors
- Zhong‐Liang Gong (ORCID: https://orcid.org/0000-0002-4713-5071)
- Yu‐Wu Zhong (ORCID: https://orcid.org/0000-0003-0712-0374)
- Rong Yang (ORCID: https://orcid.org/0000-0002-6112-3149)
- Si‐Hai Wu (ORCID: https://orcid.org/0000-0001-6188-3896)
- Jie‐Qing Liu (ORCID: https://orcid.org/0000-0002-6907-8872)
- Jiang‐Yang Shao (ORCID: https://orcid.org/0000-0002-6618-2201)
- Zhe Zhang (ORCID: https://orcid.org/0000-0002-7582-4456)
- Junjie Ma (ORCID: https://orcid.org/0000-0001-5844-9984)
- Zhong‐Qiu Li (ORCID: https://orcid.org/0000-0003-3827-3402)
- Lianhui Wang (ORCID: https://orcid.org/0000-0002-9899-3148)
- Jiao Mu
- Meirong Liu (ORCID: https://orcid.org/0009-0003-1554-2304)
- Hui-E. Peng
- Ren‐Hui Zheng (ORCID: https://orcid.org/0000-0002-0236-9675)
Institutions
- Huaqiao University (CN)
- Chinese Academy of Sciences (CN)
- Beijing National Laboratory for Molecular Sciences (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Inorganic Chemistry
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1021/acs.inorgchem.4c02515
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Quanzhou City Science and Technology Program